WASHINGTON – A new analysis of more than 865,000 abortions performed using the drug mifepristone between 2017 and 2023 found that over 10% of women experienced severe or life-threatening complications within 45 days of taking the medication, according to a report released by the Ethics and Public Policy Center (EPPC).
The EPPC study, which reviewed 865,7…